ArticleFrontiers in oncology2022

Efficacy and safety of decitabine combined with HAAG (homoharringtonine, aclarubicin, low-dose cytarabine and G-CSF) for newly diagnosed acute myeloid leukemia.

Jun-Feng Zhu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.